Category: MedTech Guide

Introduction In the highly regulated world of MedTech and Life Sciences, the path from a “good idea” to a “marketed device” is paved with objective evidence. Design Verification & Validation (V&V) are the two pillars of this evidence. While often grouped together, they serve two distinct, vital functions under 21 CFR 820.30 and ISO 13485. […]

Introduction In the highly regulated world of MedTech and Life Sciences, the path from a “good idea” to a “marketed device” is paved with objective evidence. Design Verification & Validation (V&V) are the two pillars of this evidence. While often grouped together, they serve two distinct, vital functions under 21 CFR 820.30 and ISO 13485. […]

Introduction Traditional medical software is “locked”—it produces the same output every time for a given input until a manual update is installed. AI/ML in MedTech introduces the concept of “adaptive algorithms,” which can improve their performance by learning from real-world data. Regulators like the FDA and the EMA distinguish between these two. While locked algorithms […]

Introduction The term Software as a Medical Device (SaMD) was coined by the International Medical Device Regulators Forum (IMDRF). To manage it correctly, you must first distinguish it from SiMD (Software in a Medical Device). SiMD: Software that drives a physical device (e.g., firmware for a pacemaker). It is regulated as part of the hardware. […]

Introduction In 2026, Software as a Medical Device (SaMD) and AI-driven diagnostics are the primary drivers of healthcare innovation. However, with the transition to the IEC 62304:2026 updates, compliance is no longer a post-development activity. It requires a “Compliance-as-Code” approach where the medical device software lifecycle (SDLC) is fully automated and audit-ready from day one. […]

Introduction The IEC 62304 standard provides a framework of processes, activities, and tasks for the lifecycle of medical device software. It doesn’t tell you how to code, but it mandates what you must document and verify to prove that your code won’t harm a patient. The standard covers five main processes: Software Development Process: The […]

Introduction The core message of AAMI TIR45 is simple: Agile and regulatory rigor are not mutually exclusive. In fact, the document argues that Agile’s focus on small, verified increments can actually improve safety by surfacing defects much earlier than traditional Waterfall methods. To achieve Agile Medical Device Software success, companies must stop viewing documentation as […]

Introduction The myth that the FDA or EMA requires a “Waterfall” process is dead. The technical information report AAMI TIR45 (Guidance on the use of Agile practices in the development of medical device software) is the definitive bridge. It explains how Agile Medical Device Development meets every requirement of IEC 62304 and ISO 13485 by […]

Introduction Technical safety in 2026 is driven by Safety by Design. For MedTech and Pharma companies, Failure Mode and Effects Analysis (FMEA) is the core methodology used to quantify risk through the Risk Priority Number (RPN)—a product of Severity, Occurrence, and Detection. RPN = Severity \times Occurrence \times Detection The following FMEA software for MedTech […]

Introduction In a regulated environment, “good intentions” do not count as safety. You must provide objective evidence that every identified hazard has been addressed. Closed-loop traceability is the process of linking a hazard to its mitigation and, crucially, to the evidence that the mitigation works. Without a robust traceability link, a manufacturer cannot prove that […]